AAMP Fall 2024 – The Sensitized & Reactive Patient - CME Quiz CME Quiz Step 1 of 4 25% Name* First Last Email Address*Phone Number* FRIDAY 8:15 – 9:15 Dr. Anderson Clinical Importance of Mast Cell Immunology – The Basis of the “Triad”Dr. Anderson stated clearly and MCAS – MCD immune effects are caused by:* a. Mast Cells only b. Monocytes only c. At least four cell subtypes d. None of these The immune crossover between mast cell / hypermobile / dysautonomia issues:* a. Exists b. Does not exist c. Was never spoken of 9:15 – 10:15 Dr. Baddour Recognizing and Assessing the Hypermobile Patient Symptoms are associated with hypermobility syndromes may include:* a. Joint laxity with instability-subluxations and/or dislocations b. Skin and soft tissue manifestations c. Pain d. All of these Spectra of hypermobility include:* a. Asymptomatic Joint Hypermobility (JH) b. Hypermobile spectrum disorders (HSD) c. Hypermobile Ehlers-Danlos syndrome (hEDS) d. All of these 11:00 – 12:00 Dr. Baddour Hypermobile Patients: Next Steps and Management ConsiderationsThis presentation asserted that HSD/hEDS are chronic conditions that are managed, not cured.* a. True b. False Nutritional support for these conditions was discussed:* a. True b. False 1:45 – 2:45 Dr. Tessier EDS, MCAS, CCI, ASD: Interoception and ProprioceptionOne point made in this presentation was:* a. The population with EDS, MCAS, CCI, ASD have no crossover. b. The population with EDS, MCAS, CCI, ASD are no different than all neurotypical people. c. Both of these d. Neither A or B This presentation asserted that mind-body medicine should be aggressively pushed on this clinical population:* a. True b. False 2:45 – 3:15 Dr. Anderson Primary Aggravating Comorbidities Part-1Aggravating Comorbidities include:* a. Infectious b. Endocrine c. Toxic d. All of these A common aggravating comorbidity is underlying chronic infection:* a. True b. False 4:30 – 5:15 Dr. Anderson Primary Aggravating Comorbidities Part-2Aggravating Comorbidities include:* a. Infectious b. Endocrine c. Toxic d. All of these A common aggravating comorbidity is underlying chronic infection:* a. True b. False SATURDAY 8:00 – 8:45 Dr. Anderson Infectious Comorbidity: Diagnosis and Management Part-1 Potential infectious triggers include:* a. VIRAL b. Bacterial c. Fungal d. All of these One infectious comorbidity discussed was the:* a. HHV Viral Family b. Anthrax c. Smallpox d. None of these 8:45 – 9:45 Dr. Weinstock The “Triad” MCAS – POTS – EDS Part-1The “Evil Triad” includes:* a. hEDS b. MCAS c. POTS d. All of these MCAS and Mastocytosis are the same according to this presentation:* a. True b. False SATURDAY 10:30 – 11:30 Dr. Weinstock The “Triad” MCAS – POTS – EDS Part-2The focus of this presentation was primarily:* a. Immunochemistry b. Treatment c. Neither of these It was asserted in this presentation that mast cells release over 1000 mediators:* a. True b. False 1:30 – 2:15 Dr. Anderson Infectious Comorbidity: Diagnosis and Management Part-2Potential infectious triggers include:* a. VIRAL b. Bacterial c. Fungal d. All of these One infectious comorbidity discussed was the:* a. HHV Viral Family b. Anthrax c. Smallpox d. None of these 2:15 – 3:15 Dr. Born Difficult Case Management Part - 1This presentation focused on:* a. Immunobiology b. Case Management c. Biological Drug Rx d. None of these This presentation was generally focused on ______ cases:* a. Simple, easy to cure b. Cancer c. Complex d. None of these 4:30 – 5:15 Dr. Anderson Infectious Comorbidity: Diagnosis and Management Part-3 Potential infectious triggers include:* a. VIRAL b. Bacterial c. Fungal d. All of these One infectious comorbidity discussed was the:* a. HHV Viral Family b. Anthrax c. Smallpox d. None of these SUNDAY 8:30 – 9:30 Dr. Anderson Endocrine Influences in Sensitized Patients: Assessment and ManagementThis presentation asserted that functional thyroid issues are a common comorbid condition:* a. True b. False This presentation asserted that functional cortisol issues are a common comorbid condition:* a. True b. False 9:30 – 10:30 Dr. Born Difficult Case Management Part – 2This presentation focused on:* a. Immunobiology b. Case Management c. Biological Drug Rx d. None of these This presentation was generally focused on ______ cases:* a. Simple, easy to cure b. Cancer c. Complex d. None of these 11:15 – 12:15 Dr. Anderson Immunotherapies and the Sensitized PatientOne therapy discussed was:* a. LDN b. Paraquat c. Thalomid d. None of these Vitamin D metabolism was part of this presentation:* a. True b. False 1:15 – 2:15 Dr. Tessier Addressing the Sensitized Patient: First Clinical Considerations This presentation focused on:* a. High-dose nutrient therapy b. High dose antibiotic therapy c. High dose TNFa drugs d. None of these This presentation made the point that in sensitized patients a very cautious, low dose approach with nutrients may be needed.* True False 2:15 – 3:00 Dr. Anderson Case Reviews Part-1 and Part-2This case was completed in 30 days* True False This case was:* a. Not a real patient b. An amalgamation of five people c. From many years ago d. None of these